Aurinia Pharmaceuticals Inc. 4 filing

Filed 2026-06-02 · Report date 2026-05-29 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001178579-26-000004
Form type: 4
CIK: 0001600620
Primary document: https://www.sec.gov/Archives/edgar/data/1600620/000117857926000004/xslF345X06/form4-06032026_010631.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Aurinia Pharmaceuticals Inc..

Reported financial metrics

Metric	Current	Prior	Change